Related Experiment Video

Updated: Aug 30, 2026

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
11:12

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

Published on: July 16, 2014

[Deep brain stimulation in the treatment of Parkinson's disease. Our experience]

S Ramat1, P Bono, F Ammannati

  • 1Azienda Ospedaliera Careggi, Firenze, Italy. stefano@dizzy.med.jnu.edu

Journal of Neurosurgical Sciences
|November 25, 2003
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Analysis of Gene Expression Changes in the Rat Hippocampus After Deep Brain Stimulation of the Anterior Thalamic Nucleus
09:46

Analysis of Gene Expression Changes in the Rat Hippocampus After Deep Brain Stimulation of the Anterior Thalamic Nucleus

Published on: March 8, 2015

A Novel Approach to Assess Motor Outcome of Deep Brain Stimulation Effects in the Hemiparkinsonian Rat: Staircase and Cylinder Test
07:14

A Novel Approach to Assess Motor Outcome of Deep Brain Stimulation Effects in the Hemiparkinsonian Rat: Staircase and Cylinder Test

Published on: May 31, 2016

Related Experiment Videos

Last Updated: Aug 30, 2026

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
11:12

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

Published on: July 16, 2014

Analysis of Gene Expression Changes in the Rat Hippocampus After Deep Brain Stimulation of the Anterior Thalamic Nucleus
09:46

Analysis of Gene Expression Changes in the Rat Hippocampus After Deep Brain Stimulation of the Anterior Thalamic Nucleus

Published on: March 8, 2015

A Novel Approach to Assess Motor Outcome of Deep Brain Stimulation Effects in the Hemiparkinsonian Rat: Staircase and Cylinder Test
07:14

A Novel Approach to Assess Motor Outcome of Deep Brain Stimulation Effects in the Hemiparkinsonian Rat: Staircase and Cylinder Test

Published on: May 31, 2016

Related Concept Videos

Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...

Articles linked to this work by shared authors, journal, and citation graph.

The Functional Head Impulse Test to Assess Oscillopsia in Bilateral Vestibulopathy.

Frontiers in neurology·2019

Long-term neuropathy and quality of life in colorectal cancer patients treated with oxaliplatin containing adjuvant chemotherapy.

Acta oncologica (Stockholm, Sweden)·2019

Hyponatremia associates with poor outcome in metastatic renal cell carcinoma patients treated with everolimus: prognostic impact.

Acta oncologica (Stockholm, Sweden)·2018

Combining olfactory test and motion analysis sensors in Parkinson's disease preclinical diagnosis: a pilot study.

Acta neurologica Scandinavica·2017

Everolimus-induced pneumonitis associates with favourable outcome in patients with metastatic renal cell carcinoma.

European journal of cancer (Oxford, England : 1990)·2017

A role for NMDAR-dependent cerebellar plasticity in adaptive control of saccades in humans.

Brain stimulation·2017

Impact of weak MGMT promoter methylation on the prognosis of patients with newly diagnosed glioblastoma.

Journal of neurosurgical sciences·2026

Efficacy and safety of gamma knife radiosurgery in the management of pediatric gliomas: a systematic review and meta-analysis.

Journal of neurosurgical sciences·2026

Balancing benefits and risks: bevacizumab's role in postoperative recovery after spinal oncologic neurosurgery.

Journal of neurosurgical sciences·2026

Neurosurgeons in Italy: results of a national census (2022-2024).

Journal of neurosurgical sciences·2026

Robotic versus non-robotic sacroiliac joint fusion: a meta-analysis.

Journal of neurosurgical sciences·2026

Postoperative pain management strategies in brain surgery.

Journal of neurosurgical sciences·2026

From Biological Mechanisms to Causal Inference: Quantitative Systems Pharmacology and Causal Frameworks in Drug Development.

Clinical pharmacology and therapeutics·2026

Comparative evaluation of USP II, USP IV, TIM-2, and the dynamic colon model as surrogates for human colonic drug dissolution.

RSC pharmaceutics·2026

Real-world adherence, healthcare resource utilization, and costs following a transition to aripiprazole once every 2 months among patients diagnosed with bipolar I disorder in the United States.

Frontiers in psychiatry·2026

From prediction to performance: In silico-supported formulation of amorphous solid dispersions for PROTAC NX-2127.

International journal of pharmaceutics: X·2026

Implementation Studies Funded by the National Institute on Drug Abuse on Opioid and Stimulant Use Disorders Treatment: An Updated Mapping Review (2020-2024).

Substance use & addiction journal·2026

Five-Year Clinical Outcomes of Biodegradable Versus Durable Polymer Drug-Eluting Stents: A Propensity Score-Matched Analysis of 4394 Patients.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us